Product Information
FESOTERODINE ER 4 MG TABLET is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.8333 per EA under NDC 62332017530. Its NADAC has been published 139 times since Nov 1, 2023.
Strength
4 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332017530
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FESOTERODINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA204973On Market Since
1/6/2023
Price Statistics
The NADAC for FESOTERODINE ER 4 MG TABLET has been published 139 times since Nov 1, 2023, and over the history we have for it it has declined 21.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.8333 per EA |
|---|---|
| All-time high | $1.1366 (Jan 10, 2024) |
| All-time low | $0.6489 (Jul 17, 2024) |
| 52-week high | $0.9304 |
| 52-week low | $0.8239 |
| Median price | $0.8823 |
| Average price | $0.8987 |
| Largest weekly change | +43.2% (Aug 21, 2024) |
| Weeks tracked | 139 |
| Tracking since | Nov 1, 2023 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FESOTERODINE ER 4 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FESOTERODINE ER 4 MG TABLET, manufactured by Alembic Pharmaceuticals Inc., is $0.8333 per EA (NDC 62332017530), effective Jun 24, 2026.
How has the price of FESOTERODINE ER 4 MG TABLET changed over time?
Over the history we have for it, the NADAC for FESOTERODINE ER 4 MG TABLET has declined 21.5%. It has been tracked across 139 weekly CMS publications since Nov 1, 2023.
What are the highest and lowest recorded NADAC prices for FESOTERODINE ER 4 MG TABLET?
Since Nov 1, 2023, the NADAC for FESOTERODINE ER 4 MG TABLET has ranged from a low of $0.6489 (Jul 17, 2024) to a high of $1.1366 (Jan 10, 2024), with a median of $0.8823 per EA.
Are there cheaper alternatives to FESOTERODINE ER 4 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as FESOTERODINE ER 4 MG TABLET, but none are currently priced below it.
Who manufactures FESOTERODINE ER 4 MG TABLET?
FESOTERODINE ER 4 MG TABLET (NDC 62332017530) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification